Oncology PracticePlasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With CancerNovember 8, 2024Preventive CareGastrointestinal CancerGastroenterologyMixed TopicsPatient & Survivor CareBreast CancerLung Cancer
Hematology NewsFor Radiation ‘Downwinders,’ Cancer Compensation Is On HoldOctober 25, 2024Patient & Survivor CareNon-Hodgkin LymphomaMultiple MyelomaDLBCLCMLALLAML
Oncology PracticeShould First-Line Dual Checkpoint Blockade Be Used for NSCLC With Specific Mutations?October 24, 2024Lung CancerPatient & Survivor Care
Oncology PracticeCannabis in Cancer: What Oncologists and Patients Should KnowOctober 23, 2024Patient & Survivor CarePractice ManagementPreventive CareBreast CancerCNS/Brain CancerFollicular LymphomaGastrointestinal Cancer
Oncology PracticeGotistobart Trial for NSCLC on Partial Clinical HoldOctober 23, 2024Lung CancerPatient & Survivor CarePractice Management
Oncology PracticeRisk Assessment Tool Can Help Predict Fractures in CancerOctober 21, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerFollicular LymphomaGastroenterologyGastrointestinal CancerGenitourinary Cancer
Oncology PracticeThe New Cancer Stats Might Look Like a Death Sentence. They Aren’t.October 16, 2024Nonmelanoma Skin CancerPreventive CarePatient & Survivor CareBreast CancerMelanomaLung CancerMixed Topics
Oncology PracticeMany Hurdles Exist to Treating Lung Cancer With CAR T CellsOctober 10, 2024Lung CancerImmunotherapyImmuno-oncologyPatient & Survivor CarePractice Management
Oncology Practice‘Cancer Doesn’t Wait’: How Prior Authorization Harms CareOctober 2, 2024Sarcoma & GISTPractice ManagementPatient & Survivor CareBusiness of MedicineMelanomaNonmelanoma Skin CancerBreast Cancer
Oncology PracticePopular Weight Loss Drugs Now for Patients With Cancer?September 30, 2024Breast CancerPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTPreventive CareNonmelanoma Skin CancerNeuro-oncology
Oncology PracticeMinimal Risks With SBRT in Stage I NSCLCSeptember 27, 2024Lung CancerPatient & Survivor Care
Oncology PracticeFDA Okays Osimertinib After CRT in Locally Advanced, Unresectable NSCLCSeptember 27, 2024Lung CancerPatient & Survivor CarePractice Management
Oncology PracticeDoes Medicare Advantage Offer Higher-Value Chemotherapy?September 26, 2024Practice ManagementPatient & Survivor CareRenal Cell CarcinomaSarcoma & GISTBreast CancerCNS/Brain CancerFollicular Lymphoma
Oncology PracticeAACR Cancer Progress Report: Big Strides and Big GapsSeptember 26, 2024Patient & Survivor CareMelanomaNonmelanoma Skin CancerPreventive CareLung CancerNeuro-oncologyPractice Management
